KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Treasury Shares (2016 - 2025)

Medtronic's Treasury Shares history spans 12 years, with the latest figure at $38.0 million for Q2 2025.

  • For Q2 2025, Treasury Shares rose 52.0% year-over-year to $38.0 million; the TTM value through Apr 2025 reached $38.0 million, up 52.0%, while the annual FY2025 figure was $38.0 million, 52.0% up from the prior year.
  • Treasury Shares for Q2 2025 was $38.0 million at Medtronic, up from $25.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $38.0 million in Q2 2025 and bottomed at $4.0 million in Q2 2021.
  • The 5-year median for Treasury Shares is $22.0 million (2022), against an average of $19.0 million.
  • The largest annual shift saw Treasury Shares skyrocketed 450.0% in 2022 before it plummeted 72.73% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $4.0 million in 2021, then surged by 450.0% to $22.0 million in 2022, then tumbled by 72.73% to $6.0 million in 2023, then surged by 316.67% to $25.0 million in 2024, then skyrocketed by 52.0% to $38.0 million in 2025.
  • Per Business Quant, the three most recent readings for MDT's Treasury Shares are $38.0 million (Q2 2025), $25.0 million (Q2 2024), and $6.0 million (Q2 2023).